All AbMole products are for research use only, cannot be used for human consumption.
Litifilimab is a humanized IgG1-κ antibody targeting to C-type lectin domain family 4 member C (CLEC4C). Litifilimab can be used for cutaneous lupus erythematosus (CLE) study.
Patent. CN119409823A. 2025 Feb 11.
Patent. CN119409823A
Litifilimab purchased from AbMole
Patent. CN119591712B 2025 Nov 21; .
Patent. CN119591712B
Litifilimab purchased from AbMole
| CAS Number | 2407378-48-5 |
| Form | Liquid |
| Storage | Store at ≤ -20°C. Aliquots should be stored at the same temperature after first use to avoid multiple freeze-thaws. |
| Related Immunology/Inflammation Products |
|---|
| Daratumumab
Daratumumab (Daratumumab) is a first-in-class, specific anti-CD38 monoclonal antibody (IgG1). (for human or immunodeficient mice). |
| Laquinimod
Laquinimod (ABR-215062) is a new orally active immunoregulator effectively inhibits development and relapses of experimental autoimmune encephalomyelitis. |
| Mycophenolic acid
Mycophenolic acid is an immunosuppressant agent used to prevent rejection in organ transplantation. |
| TAPI-1
TAPI-1 is an ADAM17/TACE inhibitor that blocks shedding of cytokine receptors with IC50 value of 8.09 microM. |
| Dipsacoside B
Dipsacoside B is extracted from Lonicara confusa DC. dried buds and flowers. Dipsacoside B showes strong antimicrobial activity. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
